Phase 1 first-in-human (FIH) study of nesvacumab (REGN910) a fully human and selective angiopoietin-2 (Ang2) monoclonal antibody (MAb): Results from hepatocellular carcinoma (HCC) cohort
Kelley, Robin Kate, Siu, Lillian L., Van Loon, Katherine, Tolcher, Anthony W., Razak, Albiruni R. A., Ziyeh, Sharvina, Beeram, Muralidhar, Bedard, Philippe L., Arcos, Rebecca, Gao, Bo, Trail, Pamela, Adriaens, Lieve, Brownstein, Carrie M., Lowy, Israel, Papadopoulos, Kyriakos P.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Abstract 2037: Establishment and characterization of paired mutant B-raf, vemurafenib-sensitive and -resistant patient-derived xenograft models
Wick, Michael J., Vaught, Teresa L., Gamez, Lizette, Meade, Justin, Carden, Skylar, Tolcher, Anthony W., Rasco, Drew W., Patnaik, Amita, Miller, Alexander, Drengler, Ronald, Papadopoulos, Kyriakos P.
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract LB-197: First-in-human study with ARQ 092, a novel pan AKT-inhibitor: Results from the advanced solid tumors cohorts
Saleh, Mansoor, Papadopoulos, Kyri, Arabnia, Alireza, Patnaik, Amita, Stein, Robin M., Cattaneo, Federica, Abbadessa, Giovanni, Greenberg, Jonathan, Warren, Stephen, Tolcher, Anthony
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract 3529: Effect of PNT2258, an anti-BCL2 DNA-interference drug, on tumor growth and immunological markers in mice and humans
Izbicka, Elzbieta, Streeper, Robert, Wick, Michael J., Rasco, Drew, Patnaik, Amita, Papadopoulos, Kyriakos P., Tolcher, Anthony W., Gaylor, Shari, Woolliscroft, Michael J., Messmann, Richard A., Rodrigueza, Wendi V.
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract 1398: Establishment and characterization of a clinically-relevant personalized hormone-dependent breast cancer tumor model
Wick, Michael J., Vaught, Teresa L., Gamez, Lizette, Brown, Jennifer, Moriarty, Alyssa, Tolcher, Anthony W., Rasco, Drew W., Patnaik, Amita, Rodriguez, Gladys, Drengler, Ronald L., Papadopoulos, Kyriakos P.
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
ABT-414 in patients with advanced solid tumors likely to overexpress the epidermal growth factor receptor (EGFR)
Goss, Glenwood D., Vokes, Everett E., Gordon, Michael S., Gandhi, Leena, Papadopoulos, Kyriakos P., Rasco, Drew Warren, Pedersen, Michelle, Fischer, Judee S., Chu, Katharine, Ames, William, Xiong, Hao, Lee, Ho-Jin, Zeng, Jiewei, Roberts-Rapp, Lisa, Ansell, Peter, Reilly, Ed, Holen, Kyle D., Tolcher, Anthony W.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Dose escalation stage of a first-in-class phase I study of the novel oral ERK 1/2 kinase inhibitor BVD-523 (ulixertinib) in patients with advanced solid tumors
Infante, Jeffrey R., Janku, Filip, Tolcher, Anthony W., Patel, Manish R., Sullivan, Ryan J., Flaherty, Keith, Carvajal, Richard D., Varghese, Anna M., Wong, Deborah Jean Lee, Sznol, Mario, Sosman, Jeffrey Alan, Wang-Gillam, Andrea, Burris, Howard A., Ribas, Antoni, Patel, Sapna Pradyuman, Welsch, Dean J., Saha, Saurabh
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Abstract 4426: Preclinical development of a rare tumor model: Establishment and characterization of a patient-derived collecting duct carcinoma
Thangasamy, Amalraj, Nieves, Francis, Papadopoulos, Kyriakos, Patnaik, Amita, Tolcher, Anthony, Wick, Michael J.
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article
Abstract P5-19-13: Clinical activity of abemaciclib, an oral cell cycle inhibitor, in metastatic breast cancer
Tolaney, Sara M, Rosen, Lee S, Beeram, Muralidhar, Goldman, Jonathan W, Gandhi, Leena, Tolcher, Anthony W, Papadopoulos, Kyriakos P, Rasco, Drew W, Myrand, Scott P, Kulanthaivel, Palaniappan, Andrews, Joan M, Frenzel, Martin, Cronier, Damien M, Chan, Edward M, Flaherty, Keith T, Wen, Patrick Y, Shapiro, Geoffrey I, Patnaik, Amita
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article
O82 A phase 1 dose escalation study of PRS-343, a HER2/4–1BB bispecific molecule, in patients with HER2-positive malignancies
Piha-Paul, Sarina, Bendell, Johanna, Tolcher, Anthony, Hurvitz, Sara, Patnaik, Amita, Shroff, Rachna, Pohlmann, Paula, Zettl, Markus, Hahn, Noah, Krishnamurthy, Anuradha, Duerr, Manuela, Mei, Jian, Aviano, Kayti, Yusuf, Rushdia, Matis, Louis, Olwill, Shane, Bruns, Ingmar, Ku, Geoffrey
Published in Journal for immunotherapy of cancer (01.04.2020)
Published in Journal for immunotherapy of cancer (01.04.2020)
Get full text
Journal Article
Anti-tumour activity in RAS-driven tumours by blocking AKT and MEK
Tolcher, Anthony W., Khan, Khurum, Ong, Michael, Banerji, Udai, Papadimitrakopoulou, Vassiliki, Gandara, David R., Patnaik, Amita, Baird, Richard D., Olmos, David, Garrett, Christopher R., Skolnik, Jeffrey M., Rubin, Eric H., Smith, Paul D., Huang, Pearl, Learoyd, Maria, Shannon, Keith A., Morosky, Anne, Tetteh, Ernestina, Jou, Ying-Ming, Papadopoulos, Kyriakos P., Moreno, Victor, Kaiser, Brianne, Yap, Timothy A., Yan, Li, de Bono, Johann S.
Published in Clinical cancer research (16.12.2014)
Published in Clinical cancer research (16.12.2014)
Get full text
Journal Article
Abstract CT232: Clinical activity of LY2835219, a novel cell cycle inhibitor selective for CDK4 and CDK6, in patients with metastatic breast cancer
Patnaik, Amita, Rosen, Lee S., Tolaney, Sara M., Tolcher, Anthony W., Goldman, Jonathan W., Gandhi, Leena, Papadopoulos, Kyriakos P., Beeram, Muralidhar, Rasco, Drew W., Myrand, Scott P., Kulanthaivel, Palaniappan, Li, Lily, Frenzel, Martin, Cronier, Damien M., Chan, Edward M., Flaherty, Keith T., Wen, Patrick Y., Shapiro, Geoffrey I.
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Phase I development of a weekly dosing schedule for the oral taxane tesetaxel
Lang, Amy, Beeram, Muralidhar, Tolcher, Anthony W., Papadopoulos, Kyriakos P., Drengler, Ronald, Smith, Lon S., Amaya, Alex, Barnhurst, Kelly, Itri, Loretta, Patnaik, Amita
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase I study of MK-3475 (anti-PD-1 monoclonal antibody) in patients with advanced solid tumors
Patnaik, Amita, Kang, Soonmo Peter, Tolcher, Anthony W., Rasco, Drew Warren, Papadopoulos, Kyriakos P., Beeram, Muralidhar, Drengler, Ronald, Chen, Cong, Smith, Lon, Perez, Crystal, Gergich, Kevin, Lehnert, Manfred
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Tolerability of split-dose oprozomib (ONX 0912) in patients with advanced refractory or recurrent solid tumors
Papadopoulos, Kyriakos P., Mendelson, David S., Tolcher, Anthony W., Burris, Howard A., Gordon, Michael S., Bomba, Darrin, Gillenwater, Heidi H., Infante, Jeffrey R.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Design of a phase I clinical trial with PNT2258, a novel DNA interference oligonucleotide (DNAi), in patients with advanced solid tumors
Rasco, Drew Warren, Tolcher, Anthony W., Patnaik, Amita, Papadopoulos, Kyriakos P., Amaya, Alex, Gaylor, Shari, Moore, Timothy David, Forgey, Robert, Goodwin, Neal, Bisgaier, Charles L., Rodrigueza, Wendi V.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A phase Ib study of combined angiogenesis blockade with REGN910 (SAR307746), a selective monoclonal antibody (MAb) against angiopoietin-2 (Ang2) and ziv-aflibercept in patients with advanced solid tumor malignancies
Adriaens, Lieve, Papadopoulos, Kyriakos P., Graham, Donna M., Patnaik, Amita, Razak, Albiruni R.A., Tolcher, Anthony W., Siu, Lillian L., Rasco, Drew Warren, Trail, Pamela, Brownstein, Carrie M., Lowy, Israel
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A phase I first-in-human study of REGN910 (SAR307746), a fully human and selective angiopoietin-2 (Ang2) monoclonal antibody (MAb), in patients with advanced solid tumor malignancies
Papadopoulos, Kyriakos P., Sahebjam, Solmaz, Kelley, Robin Katie, Tolcher, Anthony W., Razak, Albiruni R.A., Patnaik, Amita, Bedard, Philippe L., Arcos, Rebecca, Adriaens, Lieve, Brownstein, Carrie M., Lowy, Israel, Gao, Bo, DiCioccio, A Thomas, Trail, Pamela, Siu, Lillian L.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
First-in-human evaluation of the human monoclonal antibody vantictumab (OMP-18R5; anti-Frizzled) targeting the WNT pathway in a phase I study for patients with advanced solid tumors
Smith, David C., Rosen, Lee S., Chugh, Rashmi, Goldman, Jonathan Wade, Xu, Lu, Kapoun, Ann, Brachmann, Ranier K, Dupont, Jakob, Stagg, Robert J., Tolcher, Anthony W., Papadopoulos, Kyriakos P.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Abstract A216: Results of a phase 1, open-label, dose-escalation study evaluating the safety and tolerability of EZN-3042, a survivin mRNA antagonist, administered with docetaxel (D) in adult patients (Pts) with advanced solid tumors
Tolcher, Anthony W., Patnaik, Amita, Papadopoulos, Kyriakos P., Agnew, James, Lokiec, Francois M., Rezai, Keyvan, Kalambakas, Stacey, Buchbinder, Aby
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article